Partial deletion of the short arm of chromosome 17 syndrome

Partial deletion of the short arm of chromosome 17 syndrome (Orphanet code 261965) refers to a group of chromosomal disorders caused by the loss of genetic material from the short arm (p arm) of chromosome 17. Because chromosome 17p contains numerous genes critical for neurodevelopment, cell growth regulation, and structural protein production, deletions in this region can affect multiple body systems. The clinical presentation varies considerably depending on the size and precise location of the deletion. Affected individuals may present with intellectual disability, developmental delay, distinctive facial features, growth abnormalities, and various congenital malformations. Some well-characterized deletion syndromes involving 17p include Miller-Dieker syndrome (17p13.3 deletion, involving the LIS1 gene) and Smith-Magenis syndrome (17p11.2 deletion, involving the RAI1 gene), but this Orphanet entry encompasses partial 17p deletions more broadly, including those that do not fit neatly into a single named syndrome. The neurological system is frequently affected, with features ranging from mild learning difficulties to severe intellectual disability, seizures, and structural brain anomalies such as lissencephaly in cases involving more distal deletions. Musculoskeletal abnormalities, cardiac defects, and craniofacial dysmorphism (such as microcephaly, broad nasal bridge, and midface hypoplasia) may also be observed. Behavioral issues including sleep disturbances, self-injurious behavior, and attention difficulties have been reported in some patients. Growth retardation, both prenatal and postnatal, is a common finding. There is no cure for partial deletion of 17p. Management is supportive and multidisciplinary, tailored to the individual's specific clinical features. This may include early intervention programs, speech and occupational therapy, antiepileptic medications for seizure control, cardiac monitoring, and behavioral support. Genetic counseling is recommended for affected families. Diagnosis is typically confirmed through chromosomal microarray analysis or karyotyping.

Common questions about Partial deletion of the short arm of chromosome 17 syndrome